During the recent session, China SXT Pharmaceuticals Inc (NASDAQ:SXTC)’s traded shares were 4.58 million, with the beta value of the company hitting 1.49. At the last check today, the stock’s price was $1.51, reflecting an intraday gain of 52.69% or $0.52. The 52-week high for the SXTC share is $11.92, that puts it down -689.4 from that peak though still a striking 35.76% gain since the share price plummeted to a 52-week low of $0.97. The company’s market capitalization is $20.78M, and the average intraday trading volume over the past 10 days was 0.1 million shares, and the average trade volume was 135.10K shares over the past three months.

China SXT Pharmaceuticals Inc (NASDAQ:SXTC) trade information

China SXT Pharmaceuticals Inc (SXTC) registered a 52.69% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 52.69% in intraday trading to $1.51, hitting a weekly high. The stock’s 5-day price performance is -43.24%, and it has moved by -43.47% in 30 days. Based on these gigs, the overall price performance for the year is -88.35%. The short interest in China SXT Pharmaceuticals Inc (NASDAQ:SXTC) is 52671.0 shares and it means that shorts have 0.99 day(s) to cover.

SXTC Dividends

China SXT Pharmaceuticals Inc is due to release its next quarterly earnings in May. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

China SXT Pharmaceuticals Inc (NASDAQ:SXTC)’s Major holders

China SXT Pharmaceuticals Inc insiders own 3.17% of total outstanding shares while institutional holders control 0.18%, with the float percentage being 0.18%.

Data provided on Oct 31, 2023 indicates that Fidelity NASDAQ Composite Index Fund owns about 54.0 shares. This amounts to just over 0.00 percent of the company’s overall shares, with a $92.0 market value.